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Amphibians possess beneficial skin bacteria that protect against the disease
chytridiomycosis by producing secondary metabolites that inhibit the pathogen
Batrachochytrium dendrobatidis (Bd ). Metabolite production may be a mechanism of
competition between bacterial species that results in host protection as a by-product.
We expect that some co-cultures of bacterial species or strains will result in greater Bd
inhibition than mono-cultures. To test this, we cultured four bacterial isolates (Bacillus sp.,
Janthinobacterium sp., Pseudomonas sp. and Chitinophaga arvensicola) from red-backed
salamanders (Plethodon cinereus) and cultured isolates both alone and together to collect
their cell-free supernatants (CFS). We challenged Bd with CFSs from four bacterial
species in varying combinations. This resulted in three experimental treatments: (1) CFSs
of single isolates; (2) combined CFSs of two isolates; and (3) CFSs from co-cultures.
Pair-wise combinations of four bacterial isolates CFSs were assayed against Bd and
revealed additive Bd inhibition in 42.2% of trials, synergistic inhibition in 42.2% and no
effect in 16.6% of trials. When bacteria isolates were grown in co-cultures, complete Bd
inhibition was generally observed, and synergistic inhibition occurred in four out of six
trials. A metabolite profile of the most potent co-culture, Bacillus sp. and Chitinophaga
arvensicola, was determined with LC-MS and compared with the profiles of each isolate
in mono-culture. Emergent metabolites appearing in the co-culture were inhibitory to Bd,
and the most potent inhibitor was identified as tryptophol. Thus mono-cultures of bacteria
cultured from red-backed salamanders interacted synergistically and additively to inhibit
Bd, and such bacteria produced emergent metabolites when cultured together, with even
greater pathogen inhibition. Knowledge of how bacterial species interact to inhibit Bd can
be used to select probiotics to provide amphibians with protection against Bd.
Keywords: Batrachochytrium dendrobatidis, emergent metabolites, amphibians, symbiotic bacteria, anti-fungal
metabolites, host-associated microbial communities, interspecific competition, synergy
INTRODUCTION
Amphibians are experiencing global population declines and
are the most threatened vertebrate class (Stuart et al., 2004;
Hoffmann et al., 2010). Indeed, 41 percent of amphibian species
are threatened. Among the many factors that contribute to
amphibian declines, the fungal disease chytridiomycosis, caused
by the pathogen Batrachochytrium dendrobatidis (Bd), is the
largest disease threat to the biodiversity of any vertebrate group
(Wake and Vredenburg, 2008; Hoffmann et al., 2010). Alarmingly,
disease-induced declines occur in protected, pristine environ-
ments, such as national parks, where up to 92.5 percent of criti-
cally endangered amphibian species are affected by Bd (Kilpatrick
et al., 2010).
Amphibians have several defenses against Bd, including symbi-
otic bacteria living on their skins (Harris et al., 2006). Numerous
anti-fungal bacterial species have been cultured from amphibians
(Lauer et al., 2007; Woodhams et al., 2007), and their presence
is associated with disease resistance (Becker and Harris, 2010).
Additionally, using culture-independent techniques, diverse host-
specific bacterial communities have been observed on amphibians
(McKenzie et al., 2011; Kueneman et al., 2013; Loudon et al., 2013;
Walke et al., 2014). One promising mitigation strategy against Bd
is to augment the bacterial communities on amphibians’ skin to
increase disease resistance (Harris et al., 2009b; Bletz et al., 2013).
This approach of using bacterial probiotics has been successful
in laboratory experiments and one field trial (Becker et al., 2009;
Vredenburg et al., 2011).
Amphibian-associated bacteria can inhibit Bd by produc-
ing anti-fungal metabolites (Brucker et al., 2008a,b). Several
anti-Bd metabolites are produced from amphibian skin bac-
teria, such as violacein and indole-3-carboxaldehyde (I3C)
from Janthinobacterium lividum and 2,4-diacetylphloroglucinol
is produced Lysobacter gummosus (Brucker et al., 2008a,b).
Additionally, evidence from free-living salamanders in nature
suggests that the concentration of bacterially produced metabo-
lites on their skins can be high enough to kill pathogenic fungi,
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such as Bd (Brucker et al., 2008b).Moreover, a positive correlation
was found between the abundance of the amphibian symbiont
J. lividum and violacein on red-backed salamanders; salaman-
ders with more J. lividum and violacein had less morbidity due
to chytridiomycosis (Becker et al., 2009).
A recent model on the assembly of beneficial microbiomes
suggests that the microbiota’s defensive function is a by-product
of interspecific competition among microbial species (Scheuring
and Yu, 2012). If microbial population densities reach the point
where competition occurs and enough energy is available, defen-
sive chemical production can be triggered that may defend the
host. Without conditions of interspecific competition (pure cul-
ture), a weaker defensive function may occur. For example,
bacteria cultured separately have been found to not produce anti-
fungal compounds, but do produce anti-fungal compounds when
cultured together (De Boer et al., 2007). In this study, we tested
the hypothesis that conditions that favor interspecific competi-
tion will result in greater inhibition of Bd than under conditions
of no interspecific competition. We hypothesized that greater
inhibition of Bd would be caused by the production of emer-
gent metabolites (i.e., metabolites produced in co-culture but not
produced in mono-culture) that are only found with interspecific
competition.
MATERIALS AND METHODS
COLLECTION AND IDENTIFICATION OF ANTI-BD BACTERIAL ISOLATES
The bacterial isolates in this study were cultured from red-backed
salamanders (Plethodon cinereus) that were sampled from George
Washington National Forest in October, 2011. Four bacterial iso-
lates were chosen because they inhibit Bd in mono-culture. The
bacterial isolates were maintained in culture in 16 × 125mm test
tubes with approximately 2mL 1% tryptone broth and incu-
bated in a shaking incubator at 25◦C. Using traditional PCR,
a portion of the 16S rRNA gene was amplified using the uni-
versal 8F and 1492R primers. Reaction conditions are given in
Lauer et al. (2007). The DNA was sequenced (EuroFins MWG
Operon; Huntsville, Alabama), and Genious (Biomatters Limited;
Auckland, New Zealand) was used to assemble the forward and
reverse sequences. The GenBank database was used to identify
each bacterial isolate.
COLLECTION OF ANTI-BD BACTERIAL SPECIES’ CELL-FREE
SUPERNATANTS
To test bacterial isolates for Bd inhibition, we used a 96-well
plate assay from Bell et al. (2013). Each bacterial species was re-
cultured into a sterile 16 × 125mm test tube containing 2mL
of 1% tryptone broth for 3 days and placed in an incubator at
26◦C prior to the assay. Therefore, each culture had the same
nutrient and environmental conditions for the same amount of
time as a way to standardize growth conditions. After 3 days,
cultures were noticeably turbid. To acquire cell-free supernatants
(CFSs), each bacterial isolate was placed in a centrifuge tube and
then homogenized with a vortexer. The bacterial isolates were
then centrifuged for 5min at 10,000 rpm. After centrifugation,
the supernatants were filtered using a 0.22µm filter (Millipore™
nitrocellulose membrane), and these solutions contained bac-
terial metabolites as well as other cell products. This starting
solution was designated as the “high” concentration. “Medium”
and “low” concentrations were 10- and 100-fold dilutions, respec-
tively, of the “high” concentration, using 1X phosphate-buffered
saline solution.
DETERMINATION OF THE INDIVIDUAL AND COMBINED EFFECTS OF
ANTI-BD BACTERIAL ISOLATES ON BD INHIBITION
A concentration series of each isolate’s CFS, alone and in combi-
nation, was used in pairwise combinations with Bd in a 96 well
plate assay. All wells contained 50µL of Bd zoospores at 2 ×
106 zoospores/mL in 1% tryptone broth (105 zoospores/well).
Bd zoospores were collected using the protocol of Harris et al.
(2009b). To test the inhibitory effects of a single isolate, we added
25µLCFS and 25µLwater to each well. To test the potential addi-
tive effects of two bacterial isolates grown separately, we added
25µL of each isolate’s CFS to each well. We called the latter treat-
ment “separate then combined.” Each of these treatments was
replicated five times. Positive control wells received 50µL of ster-
ile water without any CFSs. Negative control wells received 50µL
of heat killed Bd zoospores (2 × 106 zoospores/mL), which were
killed by placing them at 60◦C for 20min. Each of these treat-
ments was replicated five times. Optical density (OD) readings
at 490 nm were obtained at day 0 and day 5. The change in OD
between days 0 and 5 indicated the amount of Bd growth in each
well, with greater differences reflecting more Bd growth.
DETERMINATION OF THE EFFECTS OF INTERSPECIFIC COMPETITION
ON BD INHIBITION
To assess the effects of interspecific bacterial competition on Bd
inhibition, bacterial species were cultured in paired combinations
for 3 days prior to assays with Bd. For these co-culture treatments,
5µL of the original culture of each bacterial species was placed
into a test tube containing 2mL of 1% tryptone broth. Mono-
cultures and additional “separate then combined” assays were
done using the procedures stated above as comparisons. Bacterial
culturing conditions were the same as the previous assay. The
co-culture wells contained 50µL of the CFS from paired com-
binations of bacterial species, and each treatment was replicated
five times.
DETECTION AND ISOLATION OF EMERGENT METABOLITES
CFC’s of monocultures and co-cultures of all isolates were
extracted with ethyl acetate according to the method of Brucker
et al. (2008a). The Bacillus sp. and Chitinophaga arvensicola com-
bination was focused on since they resulted in the greatest Bd
inhibition in co-culture. The resulting crude extracts were evap-
orated to dryness in vacuo, reconstituted in 0.75mL methanol,
and analyzed by reversed-phase, high performance liquid chro-
matography (HPLC, 25µL injection) using a Shimadzu LC-20
liquid chromatograph equipped with an ACE C18 column (3µm,
150 × 4.6mm) according to the method of Umile et al. (2014).
Comparison of the chromatograms showed the appearance of
at least six metabolites in the co-culture that were not present
in either monoculture (Figure 3). Metabolite peaks that were
observed in co-cultures, but not present in either of the two indi-
vidual cultures, were identified as emergent metabolites. These
metabolites were isolated by semi-preparative HPLC [ACE C18
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column (5µm, 250 × 10mm)] and assayed for bioactivity toward
Bd (see below). To test this, each fraction was suspended in 5%
DMSO solution, to facilitate the dissolution of metabolites. 10µL
of each metabolite solution was added to 40µL of a Bd zoospore
solution resulting in a final concentration of 106 zoospores/mL.
The final concentration of each metabolite was ≈2µg/mL. In
addition, tests were performed without the use of DMSO as
a co-solvent with low concentrations of each metabolite that
were not quantified. These tests suggested that the compound
eluting at 13.48min (“Compound 3”) was the most inhibitory
(Figure 4).
CHARACTERIZATION AND IDENTIFICATION OF “COMPOUND 3”
An inhibitory compound eluting at 13.48min (“Compound 3”)
was isolated using the semi-preparative HPLC described above
and analyzed by 1H NMR and liquid chromatography-mass spec-
trometry (LC-MS). 1H NMR spectra were measured with a
300MHz Varian spectrophotometer. UV-Vis measurements uti-
lized a Shimadzu SPD-M20A diode array detector, and mass
spectrometry used an Applied Biosystems SCIEX API 2000 triple
quadrupole mass spectrometer operating in positive electrospray
ionization mode.
BIOASSAY WITH METABOLITE AND BD
The IC50 for the emergent metabolite, tryptophol, against Bd
strain JEL310 was determined using a 96 well plate method assay
previously developed by Brucker et al. (2008a).
STATISTICAL ANALYSES
Analyses of variance (ANOVA) were used to test for the main
effects of species’ CFS on Bd inhibition. A significant interac-
tion effect indicated that either synergy or antagonism between
species’ CFS was present. Dunnett’s test was used for a posteriori
tests to compare treatments to controls, and Tukey’s test was used
to compare each treatment to each other to identify an interaction
effect (synergy or antagonism) when one was present.
RESULTS
BACTERIAL IDENTIFICATION
Isolates were determined to be a Bacillus sp., Janithobacterium
sp., Pseudomonas sp., and Chitinophaga arvensicola (Table 1;
sequences Genbank accession #’s KJ923801, KJ923802, KJ923803
and KJ923804 respectively). The genera of all four isolates were
represented within the Illumina dataset presented in Loudon et al.
(2013). In addition, OTUs within the family Pseudomonadaceae
were within the core bacterial community and Janthinobacterium
lividum was highly prevalent on red-backed salamanders.
“SEPARATE THEN COMBINED” ASSAYS
To determine the effect of combined bacterial isolates on Bd inhi-
bition we used a “separate then combined” assay where isolates
were first grown in mono-culture, and then combined together to
challenge Bd. The six combinations of the four bacterial species’
CFSs demonstrated several effects on the growth of Bd in com-
parison to the positive Bd control (Supplementary Table 1).
The “separate then combined” results for Pseudomonas sp. and
Chitinophaga arvensicola were not included due to failure of the
positive controls; this resulted in 45 “separate then combined”
Table 1 | Identities of anti-Bd bacterial isolates used in inhibition
assays.
Identity % match E -value Accession number
Bacillus sp.* 100 0 KJ923801
Pseudomonas sp.* 100 0 KJ923802
Janthinobacterium sp.* 99 0 KJ923803
Chitinophaga arvensicola 99 0 KJ923804
*Isolates were only identified to the Genus level.
combinations. Of the 45 combinations assayed, some produced
an additive effect when assayed with Bd, some synergistically
inhibited the growth of Bd in comparison to the positive control,
and others had no effect on Bd growth.
Of the total of 45 isolate-CFS concentration combinations, 19
of these exhibited an additive relationship when assayed against
Bd. These pairs showed an effect on Bd growth equal to the sum
of the effects of the CFSs of each species. One example of an
additive relationship was between the medium concentration of
Bacillus sp. CFS and the low concentration of Janthinobacterium
sp. CFS (Figure 1A). There was a tendency of high concentration
combination of both isolates to have additive effects as well.
There were 19 isolate-CFS concentration combinations that
inhibited Bd synergistically. These combinations inhibited Bd
with a greater total effect than the additive relationship.
Concentration combinations were identified as synergistic if their
statistical interactions were significant. For example, the combi-
nations of the medium concentration of Bacillus sp. CFS with
themedium concentration of Pseudomonas sp. resulted in synergy
(Figure 1B).
CO-CULTURE ASSAYS
The CFSs from co-cultured bacterial isolates showed greater inhi-
bition of Bd than the “separate then combined” CFSs in some
cases. Out of the six co-culture combinations, four resulted
in synergistic inhibition of Bd, one resulted in additive inhi-
bition of Bd, and one resulted in synergistic facilitation of
Bd (Supplementary Table 2). The co-cultured combinations
of Bacillus sp./Janthinobacterium sp., Bacillus sp./Pseudomonas
sp., Bacillus sp./C. arvensicola (Figure 2) and Janthinobacterium
sp./C. synergistically inhibited Bd. The co-culture combination
of Pseudomonas sp./C. arvensicola additively inhibited Bd. Lastly,
the combination Pseudomonas sp./Janthinobacterium sp. synergis-
tically facilitated Bd.
The “separate then combined” assays that were repeated for
a comparison with the co-culture assays sometimes differed
from initial “separate then combined” trials. For the Bacillus
sp./ Pseudomonas sp. combination, the “separate then combined”
treatments from the two different trials were significantly dif-
ferent between trials. These comparisons were performed after
standardizing the OD values by the positive controls from the two
different assays.
EMERGENT METABOLITES
The co-culture between Bacillus sp. and Chitinophaga arvensi-
cola produced seven isolated emergent metabolites (Figure 3) that
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FIGURE 1 | (A,B) Representative results from “separate then combined”
assays. (A) Additive Bd inhibition with a medium concentration of Bacillus
and Janthinobacterium (ANOVA- Bacillus p = 0.0011;
Janthinobacterium p = 0.0008; Interaction p = 0.8277). (B) Synergisytic
inhibition of Bd with a medium concentration of Bacillus and Pseudomonas
sp. A (ANOVA- Bacillus p = 0.0512; Pseudo A p = 0.0239; Interaction
p = 0.0025).
were all inhibitory to Bd growth at an approximate concentration
of 2µg/mL. An additional test that did not use DMSO as a co-
solvent and using low unquantified metabolite concentrations
revealed that three compounds were inhibitory, with Compound
3 being the most inhibitory (Figure 4).
Compound 3 was identified as tryptophol by multiple chem-
ical methods (UV-Vis spectroscopy, mass spectrometry, and 1H
NMR spectroscopy). Accordingly, isolated Compound 3 and an
authentic tryptophol standard co-elute (13.48min) and share a
characteristic indole chromophore with peaks at 280 and 289 nm
(Figure 5). Additionally, ESI-MS of a tryptophol standard and
Compound 3 both show a characteristic 144m/z peak corre-
sponding to an [M—H2O]+ ion; finally, the 1H NMR spectrum
of isolated Compound 3 matches that of authentic tryptophol.
Authentic tryptophol inhibited Bd (Figure 6) and displayed an
IC50 of ∼100 ppm (∼600µM).
The metabolite profiles for Pseudomonas sp. and
Janthinobacterium sp. were also examined since this combi-
nation resulted in Bd facilitation. Janthinobacterium sp. had three
metabolites that were present in the mono-culture that were
not present in the co-culture; therefore, Bd was challenged with
a different suite of metabolites than when challenged with the
mono-cultures.
DISCUSSION
Combinations of bacterial isolate’s CFSs exhibited several dif-
ferent relationships in the inhibition of Bd, demonstrating that
the isolates, and the concentrations of an isolate’s CFSs, are
important factors in Bd inhibition. In some cases, the inhibition
caused by two isolates CFSs had an additive effect on Bd growth
inhibition. Other combinations inhibited Bd growth synergisti-
cally. Some combinations did not demonstrate any effect on Bd
growth.
The in vitro model of combining CFSs can represent spatially
separated isolates on amphibian skin whose secreted metabolites
combine in the interstices between them. The different rela-
tionships among the pairwise combinations between the four
isolates in high, medium and low concentrations demonstrate
the variability of bacterial interactions that are likely found in
nature. It is unknown how isolates are distributed on amphib-
ian skins, much less their relative population densities, but it
is likely to be variable even on a single host individual. In
an additive relationship, the metabolites of both bacterial iso-
lates are contributing equally to the inhibition of Bd growth.
Synergistic relationships may be the result of anti-fungals with
different modes of action (Ghannoum and Rice, 1999). As a
hypothetical example, in our system a metabolite from the
first bacterial isolate may puncture the cell wall of Bd, whereas
the metabolites from the second bacterial isolate may inhibit
translation.
Emergent metabolites were identified that were present in bac-
terial co-cultures, but not present in bacterial mono-cultures.
CFSs from co-cultures were often more inhibitory of Bd than
combining CFSs from mono-cultures. Co-culturing is a model
of isolates on the skins that are in the same or close spa-
tial location and are competing with each other by start-
ing to produce additional inhibitory metabolites, and these
new metabolites are one reason for greater inhibition of Bd.
Furthermore, emergent metabolites may be synergistically inter-
acting with the metabolites produced in mono-culture and
other emergent metabolites to enhance their collective killing
power. We determined that these emergent metabolites are
anti-Bd and determined the identity and IC50 of the most
inhibitory metabolite, tryptophol. Although it is inhibitory, it
is much less potent than previously identified anti-Bd metabo-
lites such as violacein (Brucker et al., 2008b). Tryptophol has
been found to be produced by fungi such as Ceratocystis adi-
pose (Guzmán-López et al., 2007), Candida albicans (Lingappa
et al., 1969), Pythium ultimum (Rey et al., 2001), Drechslera
nodulosum (Sugawara and Strobel, 1987), and Zygosaccharomyces
priorianus (Rosazza et al., 1973). The mechanism that tryp-
tophol uses to inhibit Bd is unknown. We hypothesize that these
emergent metabolites are interacting to cause the greater Bd
inhibition found in the co-culture assays. The strong inhibition
of Bd caused by the co-culture CFSs supports the hypothe-
sis that interspecific competition led to greater Bd inhibition
than intraspecific competition alone (De Boer et al., 2007;
Scheuring and Yu, 2012). Furthermore, it suggests that compet-
ing microbial species in amphibian skins would enhance disease
protection.
One case of facilitation occurred in co-culture between
Pseudomonas sp. and Janthinobacterium sp. This result is intrigu-
ing since when the bacteria were grown separately and then
combined, they did not result in facilitation. Previous work
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FIGURE 2 | Representative results of co-culture vs. mono-culture assay
using Bacillus sp. and Chitinophaga arvensicola (Different letters
indicate that treatments are significantly different at p < 0.05 level
using Tukey’s test). The “separate then combined” results for this isolate
combination are also included as a comparison.
FIGURE 3 | LC-MS chromatograms of ethyl acetate extracts from
monocultures of Bacillus and Chitinophaga arvensicola and a
co-culture of the two. Gray bars indicate emergent metabolites found in
the co-culture that were not present in either monoculture. (Absorbance
axes not to common scale.) Metabolites are labeled 1–6; metabolite 7 has a
retention time greater than what is shown in this figure and is therefore not
present.
using a similar protocol to determine bacteria’s effect on Bd
found facilitation of Bd growth by some isolate’s CFSs (Bell
et al., 2013). Pseudomonas can produce a number of antifungal
metabolites and Janthinobacterium has been widely studied as an
anti-Bd bacterium, so facilitation of Bd was surprising. In our
study, the co-culture lacked metabolites that were found in the
Janthinobacterium mono-culture. This shift in metabolites may
have led to the facilitation of Bd.
When the “separate then combined” assays were repeated, the
results differed to some extent between trials. In particular, syn-
ergy between certain pairs of isolates in the first experiment was
not always found in the second experiment. A possible reason for
this is that isolates were under somewhat different densities in
culture due to stochastic variation. As a result, isolates produced
different concentrations ofmetabolites that then interacted differ-
ently when combined. An additional reason may be the age of the
media used or the use of different batches of media that had slight
chemical differences. Also, it is possible that mutation in labora-
tory stocks led to different outcomes in the assays. However, all of
the results demonstrate that additive and synergistic interactions
occur among amphibians’ skin bacteria, which depend on a vari-
ety of factors, including bacterial species identify and chemical
concentration.
The inhibitory interactions between different bacterial species
are not the only chemical interactions that inhibit Bd within
the amphibian skin system. Myers et al. (2012) found synergistic
interactions between the antimicrobial peptides (AMPs) from the
skin of the frog, Rana muscosa, and the known anti-Bdmetabolite
2,4-diacetylphloroglucinol (2,4-DAPG), which is produced by the
bacterium Pseudomonas fluorescens. It is likely that AMPs interact
with other bacterially-produced metabolites to inhibit Bd, espe-
cially since we found that bacteria produce a high richness of
metabolites. Bacteria also produce AMPs that may inhibit Bd,
although we focused on smaller metabolites that are produced by
bacteria.
Our results support the hypothesis that competition between
different bacterial species causes greater Bd inhibition. Bacterial
species compete through the production of defensive compounds,
which leads to their competitive dominance. Therefore, the
host obtains a defensive benefit as a by-product of microbial
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FIGURE 4 | Inhibitory properties of emergent metabolite fractions 1–7 at low unquantifiable concentrations. An additional control, “metabolite negative
control,” was also included, which was a fraction that contained no metabolites. The bars reflect standard deviation.
FIGURE 5 | UV-Vis spectra of isolated Compound 3 and an authentic
tryptophol standard.
competition. Results from theory suggest that beneficial,
antibiotic-producing bacteria are favored over bacteria that do
not produce such compounds as long as the host supplies
adequate resources for antibiotic production (Scheuring and
Yu, 2012). Although we expect that competition has driven
the production of emergent metabolites and an overall greater
inhibitory function, competition was not measured, and it is
FIGURE 6 | Bd challenge assay to determine the IC50 of the emergent
metabolite tryptophol. The bars reflect standard deviation.
possible that other interactions, such as cooperation, led to our
results.
This work reveals the complexity of microbial interactions
and emphasizes the importance of considering such interactions
when developing a bacterial probiotic as a conservation strat-
egy. Furthermore, our results suggest that a bacterial probiotic
with multiple bacterial species is more promising than a bacte-
ria probiotic with a single bacterial species. Although a single
trial to test bacterial probiotics with multiple bacterial species
was unsuccessful on amphibians (Bletz et al., 2013), more work
is needed to fully assess the potential of such therapy. Probiotic
trials with a single isolate have been successful in some cases
(Harris et al., 2009a,b), but not in others (Becker et al., 2011;
Bletz et al., 2013). This variation could be explained by the pro-
biotic interacting synergistically with the resident microbiota to
inhibit Bd in the successful cases, but not synergistically inhibiting
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Bd or even facilitating Bd the unsuccessful cases. Bacterial probi-
otics withmultiple bacterial species have been successful inmouse
intestines (Lawley et al., 2012). In this study, the successful com-
bination of bacteria used in the probiotic was selected by trial
and error. This strategy was successful, however not efficient. It
is likely important to choose bacteria that will compete inter-
specifically and producemore inhibitory metabolites. We propose
choosing bacteria that display additive or synergistic relationships
when in combination with other isolates over a range of concen-
trations and be highly inhibitory when co-cultured. If a bacterial
isolate does not have an effect on Bd growth and does not pro-
duce any effect when combined with a second bacterial isolate,
then it should be excluded from further consideration as part of a
probiotic solution. To test whether the addition of multiple pro-
biotics on amphibians worked in vivo, the defensive function of
the mucosome could be measured, which would determine if the
chemicals on an amphibian are anti-fungal prior to infection by
a pathogen (Woodhams et al., 2014). Our results provide support
for the use of a co-culture method in probiotic development that
may lead to a more effective probiotic solution.
In conclusion, we found that metabolites produced by
amphibians’ skin bacteria in monoculture can be combined, and
they can interact synergistically with each other to inhibit Bd.
In addition, we found that when these bacteria were co-cultured
they were often even more inhibitory to Bd, and they produced
emergent metabolites that were not made by the bacteria when in
monoculture. Furthermore, we identified the emergent metabo-
lite tryptophol, which was the most active emergent metabolite
against Bd. These results will aid in developing combination of
probiotics to mitigate the amphibian disease chytridiomycosis,
in addition to contributing to our knowledge of bacterial and
chemical interactions.
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